Biohaven Pharma (BHVN) Tops Q4 EPS by 28c
Tweet
Share
E-mail
Get Alerts BHVN Hot Sheet
Join SI Premium – FREE
Biohaven Pharma (NYSE: BHVN) reported Q4 EPS of ($0.90), $0.28 better than the analyst estimate of ($1.18).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UGI shares spike on reported KKR bid for the company
- Vishay launches compact proximity sensor with 5 μA idle current
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
